Proactive - Interviews for investors
Santhera Pharmaceuticals CFO on strong FY25 performance & AGAMREE expansion
Santhera Pharmaceuticals CFO Catherine Isted discusses the company's strong 2025 financial performance, including a near doubling of revenues and robust AGAMREE sales. The discussion covers European market expansion, product safety data, and future partnership opportunities…